Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.15 USD | -3.93% | +0.10% | -17.01% |
Financials (USD)
Sales 2024 * | 132M | Sales 2025 * | 210M | Capitalization | 2.33B |
---|---|---|---|---|---|
Net income 2024 * | -280M | Net income 2025 * | -133M | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | 416M | Net cash position 2025 * | 288M | EV / Sales 2025 * | 9.72 x |
P/E ratio 2024 * |
-9.15
x | P/E ratio 2025 * |
-19
x | Employees | 226 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.1% |
Latest transcript on Rhythm Pharmaceuticals, Inc.
1 day | -3.93% | ||
1 week | +0.10% | ||
Current month | -11.95% | ||
1 month | -3.78% | ||
3 months | -13.65% | ||
6 months | +72.62% | ||
Current year | -17.01% |
Managers | Title | Age | Since |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 15-10-31 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 17-06-30 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 15-03-31 |
Jennifer Good
BRD | Director/Board Member | 59 | 19-06-18 |
David McGirr
BRD | Director/Board Member | 69 | 15-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.09% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 38.15 | -3.93% | 424,460 |
24-04-24 | 39.71 | -0.72% | 398,307 |
24-04-23 | 40 | +2.54% | 413,704 |
24-04-22 | 39.01 | +2.63% | 390,372 |
24-04-19 | 38.01 | -0.26% | 615,979 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.01% | 2.33B | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.73% | 22.02B | |
-17.84% | 20.9B | |
-8.86% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- RYTM Stock